The Filings Report

UnitedHealth Group

UNHNYSECIK 731766Healthcare / Healthcare Plansfiscal year ends December73 quarters since 2008

Revenue, Q2 FY2026
$112.0B
+0.4% on Q2 FY2025
Net income
$5.5B
+61.0% on Q2 FY2025
Free cash flow
$10.3B
+62.7% on Q2 FY2025
Diluted EPS
$6.04
+61.5% on Q2 FY2025
Revenue, TTM
$450.1B
trailing four quarters
Net margin, TTM
3.1%
net income $14.1B
Free cash flow, TTM
$23.6B
$27.0B less $3.4B capex
Cash and equivalents
$28.6B
long-term debt $69.5B, Jun 30, 2026
Shares, 12-month change
−0.9%
898M shares, Jun 30, 2026
Buybacks, TTM
$1.6B
0.5% of market value
Dividends, TTM
$8.1B
2.2% of market value
Market value
$365.3B
at the close, buybacks

Latest quarter Q2 FY2026, filed August 10, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q2 FY2026, the quarter ended June 30, 2026, UnitedHealth Group reported revenue of $112.0B, +0.4% on Q2 FY2025, and net income of $5.5B (+61.0%). Operating margin was 7.1%. Free cash flow, operating cash flow less capital expenditures, was $10.3B ($11.1B less $799M). Diluted earnings per share were $6.04.

The last 16 quarters

Q3 FY2022 to Q2 FY2026, through the filing of August 10, 2026.

Revenue and net incomeRevenueNet income
−$50B$0$50B$100B$150BQ3'22, Revenue: $80.9BQ3'22, Net income: $5.3BQ3'22Q4'22, Revenue: $82.8BQ4'22, Net income: $4.8BQ4'22Q1'23, Revenue: $91.9BQ1'23, Net income: $5.6BQ1'23Q2'23, Revenue: $92.9BQ2'23, Net income: $5.5BQ2'23Q3'23, Revenue: $92.4BQ3'23, Net income: $5.8BQ3'23Q4'23, Revenue: $94.4BQ4'23, Net income: $5.5BQ4'23Q1'24, Revenue: $99.8BQ1'24, Net income: −$1.4BQ1'24Q2'24, Revenue: $98.9BQ2'24, Net income: $4.2BQ2'24Q3'24, Revenue: $100.8BQ3'24, Net income: $6.1BQ3'24Q4'24, Revenue: $100.8BQ4'24, Net income: $5.5BQ4'24Q1'25, Revenue: $109.6BQ1'25, Net income: $6.3BQ1'25Q2'25, Revenue: $111.6BQ2'25, Net income: $3.4BQ2'25Q3'25, Revenue: $113.2BQ3'25, Net income: $2.3BQ3'25Q4'25, Revenue: $113.2BQ4'25, Net income: $10MQ4'25Q1'26, Revenue: $111.7BQ1'26, Net income: $6.3BQ1'26Q2'26, Revenue: $112.0BQ2'26, Net income: $5.5BQ2'26−$50B$0$50B$100B$150BQ3'22, Revenue: $80.9BQ3'22, Net income: $5.3BQ4'22, Revenue: $82.8BQ4'22, Net income: $4.8BQ4'22Q1'23, Revenue: $91.9BQ1'23, Net income: $5.6BQ2'23, Revenue: $92.9BQ2'23, Net income: $5.5BQ2'23Q3'23, Revenue: $92.4BQ3'23, Net income: $5.8BQ4'23, Revenue: $94.4BQ4'23, Net income: $5.5BQ4'23Q1'24, Revenue: $99.8BQ1'24, Net income: −$1.4BQ2'24, Revenue: $98.9BQ2'24, Net income: $4.2BQ2'24Q3'24, Revenue: $100.8BQ3'24, Net income: $6.1BQ4'24, Revenue: $100.8BQ4'24, Net income: $5.5BQ4'24Q1'25, Revenue: $109.6BQ1'25, Net income: $6.3BQ2'25, Revenue: $111.6BQ2'25, Net income: $3.4BQ2'25Q3'25, Revenue: $113.2BQ3'25, Net income: $2.3BQ4'25, Revenue: $113.2BQ4'25, Net income: $10MQ4'25Q1'26, Revenue: $111.7BQ1'26, Net income: $6.3BQ2'26, Revenue: $112.0BQ2'26, Net income: $5.5BQ2'26

Net income losses drawn in red.

Free cash flow
−$10B$0$10B$20BQ3'22, Free cash flow: $17.8BQ3'22Q4'22, Free cash flow: −$5.4BQ4'22Q1'23, Free cash flow: $15.6BQ1'23Q2'23, Free cash flow: $10.2BQ2'23Q3'23, Free cash flow: $6.1BQ3'23Q4'23, Free cash flow: −$6.2BQ4'23Q1'24, Free cash flow: $401MQ1'24Q2'24, Free cash flow: $5.9BQ2'24Q3'24, Free cash flow: $13.0BQ3'24Q4'24, Free cash flow: $1.5BQ4'24Q1'25, Free cash flow: $4.6BQ1'25Q2'25, Free cash flow: $6.3BQ2'25Q3'25, Free cash flow: $5.1BQ3'25Q4'25, Free cash flow: $160MQ4'25Q1'26, Free cash flow: $8.1BQ1'26Q2'26, Free cash flow: $10.3BQ2'26−$10B$0$10B$20BQ3'22, Free cash flow: $17.8BQ4'22, Free cash flow: −$5.4BQ4'22Q1'23, Free cash flow: $15.6BQ2'23, Free cash flow: $10.2BQ2'23Q3'23, Free cash flow: $6.1BQ4'23, Free cash flow: −$6.2BQ4'23Q1'24, Free cash flow: $401MQ2'24, Free cash flow: $5.9BQ2'24Q3'24, Free cash flow: $13.0BQ4'24, Free cash flow: $1.5BQ4'24Q1'25, Free cash flow: $4.6BQ2'25, Free cash flow: $6.3BQ2'25Q3'25, Free cash flow: $5.1BQ4'25, Free cash flow: $160MQ4'25Q1'26, Free cash flow: $8.1BQ2'26, Free cash flow: $10.3BQ2'26

Operating cash flow less capital expenditures; negative quarters in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$20B$40B$60B$80BQ3'22, Cash and equivalents: $38.8BQ3'22, Long-term debt: $45.4BQ3'22Q4'22, Cash and equivalents: $23.4BQ4'22, Long-term debt: $54.5BQ4'22Q1'23, Cash and equivalents: $41.9BQ1'23, Long-term debt: $60.7BQ1'23Q2'23, Cash and equivalents: $41.8BQ2'23, Long-term debt: $59.3BQ2'23Q3'23, Cash and equivalents: $38.9BQ3'23, Long-term debt: $58.1BQ3'23Q4'23, Cash and equivalents: $25.4BQ4'23, Long-term debt: $58.3BQ4'23Q1'24, Cash and equivalents: $28.4BQ1'24, Long-term debt: $63.9BQ1'24Q2'24, Cash and equivalents: $26.3BQ2'24, Long-term debt: $63.7BQ2'24Q3'24, Cash and equivalents: $32.4BQ3'24, Long-term debt: $74.1BQ3'24Q4'24, Cash and equivalents: $25.3BQ4'24, Long-term debt: $72.4BQ4'24Q1'25, Cash and equivalents: $30.7BQ1'25, Long-term debt: $71.3BQ1'25Q2'25, Cash and equivalents: $28.6BQ2'25, Long-term debt: $73.5BQ2'25Q3'25, Cash and equivalents: $27.2BQ3'25, Long-term debt: $72.4BQ3'25Q4'25, Cash and equivalents: $24.4BQ4'25, Long-term debt: $72.3BQ4'25Q1'26, Cash and equivalents: $28.0BQ1'26, Long-term debt: $71.4BQ1'26Q2'26, Cash and equivalents: $28.6BQ2'26, Long-term debt: $69.5BQ2'26$0$20B$40B$60B$80BQ3'22, Cash and equivalents: $38.8BQ3'22, Long-term debt: $45.4BQ4'22, Cash and equivalents: $23.4BQ4'22, Long-term debt: $54.5BQ4'22Q1'23, Cash and equivalents: $41.9BQ1'23, Long-term debt: $60.7BQ2'23, Cash and equivalents: $41.8BQ2'23, Long-term debt: $59.3BQ2'23Q3'23, Cash and equivalents: $38.9BQ3'23, Long-term debt: $58.1BQ4'23, Cash and equivalents: $25.4BQ4'23, Long-term debt: $58.3BQ4'23Q1'24, Cash and equivalents: $28.4BQ1'24, Long-term debt: $63.9BQ2'24, Cash and equivalents: $26.3BQ2'24, Long-term debt: $63.7BQ2'24Q3'24, Cash and equivalents: $32.4BQ3'24, Long-term debt: $74.1BQ4'24, Cash and equivalents: $25.3BQ4'24, Long-term debt: $72.4BQ4'24Q1'25, Cash and equivalents: $30.7BQ1'25, Long-term debt: $71.3BQ2'25, Cash and equivalents: $28.6BQ2'25, Long-term debt: $73.5BQ2'25Q3'25, Cash and equivalents: $27.2BQ3'25, Long-term debt: $72.4BQ4'25, Cash and equivalents: $24.4BQ4'25, Long-term debt: $72.3BQ4'25Q1'26, Cash and equivalents: $28.0BQ1'26, Long-term debt: $71.4BQ2'26, Cash and equivalents: $28.6BQ2'26, Long-term debt: $69.5BQ2'26

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q2 FY2026 filed August 10, 2026.

UnitedHealth Group income statement, quarterly
Millions of dollarsQ2 FY2026ended Jun 30, 2026filed Aug 10, 2026Q1 FY2026ended Mar 31, 2026filed May 5, 2026Q4 FY2025ended Dec 31, 2025filed Mar 2, 2026Q3 FY2025ended Sep 30, 2025filed Oct 28, 2025Q2 FY2025ended Jun 30, 2025filed Aug 11, 2025Q1 FY2025ended Mar 31, 2025filed May 7, 2025Q4 FY2024ended Dec 31, 2024filed Feb 27, 2025Q3 FY2024ended Sep 30, 2024filed Nov 4, 2024YoYQ2 FY2026vs Q2 FY2025
Revenue112,032111,721113,215113,161111,616109,575100,807100,820+0.4%
Cost of revenue13,37512,82312,68012,56613,01912,39012,46411,834+2.7%
Gross profit—————————
Research and development—————————
Selling, general and administrative14,26815,39016,99715,22313,77813,59412,49413,280+3.6%
Operating income7,9918,9903804,3155,1509,1197,7738,708+55.2%
Other income (expense)—————————
Pretax income6,9687,963(720)3,2294,0828,1066,7917,614+70.7%
Income tax1,2981,482(938)6865101,6321,0071,356+154.5%
Net income5,4846,280102,3483,4066,2925,5436,055+61.0%
Diluted EPS ($)6.046.90—2.593.746.85—6.51+61.5%
Diluted shares (millions)906910—908910918—930—

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q2 FY2026 filed August 10, 2026.

UnitedHealth Group balance sheet, quarterly
Millions of dollarsQ2 FY2026ended Jun 30, 2026filed Aug 10, 2026Q1 FY2026ended Mar 31, 2026filed May 5, 2026Q4 FY2025ended Dec 31, 2025filed Mar 2, 2026Q3 FY2025ended Sep 30, 2025filed Oct 28, 2025Q2 FY2025ended Jun 30, 2025filed Aug 11, 2025Q1 FY2025ended Mar 31, 2025filed May 7, 2025Q4 FY2024ended Dec 31, 2024filed Feb 27, 2025Q3 FY2024ended Sep 30, 2024filed Nov 4, 2024YoYQ2 FY2026vs Q2 FY2025
Cash and equivalents28,58528,00124,36527,21028,59630,71725,31232,400−0.0%
Short-term investments2,8833,2283,7563,4043,4243,5743,8014,734−15.8%
Total current assets86,86091,12790,58295,06793,69996,28585,77992,258−7.3%
Total assets309,727312,644309,581315,269308,573309,790298,278299,309+0.4%
Total current liabilities111,820114,124114,897115,526110,781113,471103,769101,565+0.9%
Long-term debt69,50171,44072,32072,39973,49571,28572,35974,101−5.4%
Total liabilities203,778207,325207,883209,456203,789204,621195,687194,854−0.0%
Stockholders’ equity104,513103,895100,090101,569100,469100,81198,26899,881+4.0%
Shares outstanding (millions)898908908906906907915920—

Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q2 FY2026 filed August 10, 2026.

UnitedHealth Group cash flow statement, quarterly
Millions of dollarsQ2 FY2026ended Jun 30, 2026filed Aug 10, 2026Q1 FY2026ended Mar 31, 2026filed May 5, 2026Q4 FY2025ended Dec 31, 2025filed Mar 2, 2026Q3 FY2025ended Sep 30, 2025filed Oct 28, 2025Q2 FY2025ended Jun 30, 2025filed Aug 11, 2025Q1 FY2025ended Mar 31, 2025filed May 7, 2025Q4 FY2024ended Dec 31, 2024filed Feb 27, 2025Q3 FY2024ended Sep 30, 2024filed Nov 4, 2024YoYQ2 FY2026vs Q2 FY2025
Operating cash flow11,0528,9121,1085,9457,1885,4562,36913,945+53.8%
Capital expenditures799763948890886898912991−9.8%
Free cash flow (CFO − capex)10,2538,1491605,0556,3024,5581,45712,954+62.7%
Depreciation and amortization1,0401,0291,1171,0991,0841,0611,0411,041−4.1%
Share repurchases1,6460002,5453,0004,972956−35.3%
Dividends paid2,0872,0052,0022,0022,0001,9121,9321,937+4.3%

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2025 filed March 2, 2026.

Income statement

UnitedHealth Group income statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Mar 2, 2026FY2024ended Dec 31, 2024filed Feb 27, 2025FY2023ended Dec 31, 2023filed Feb 28, 2024FY2022ended Dec 31, 2022filed Feb 24, 2023FY2021ended Dec 31, 2021filed Feb 15, 2022FY2020ended Dec 31, 2020filed Mar 1, 2021FY2019ended Dec 31, 2019filed Feb 14, 2020FY2018ended Dec 31, 2018filed Feb 12, 2019FY2017ended Dec 31, 2017filed Feb 13, 2018FY2016ended Dec 31, 2016filed Feb 8, 2017FY2015ended Dec 31, 2015filed Feb 9, 2016FY2014ended Dec 31, 2014filed Feb 10, 2015FY2013ended Dec 31, 2013filed Feb 12, 2014FY2012ended Dec 31, 2012filed Feb 7, 2013FY2011ended Dec 31, 2011filed Feb 9, 2012FY2010ended Dec 31, 2010filed Feb 10, 2011FY2009ended Dec 31, 2009filed Feb 10, 2010FY2008ended Dec 31, 2008filed Aug 6, 2009FY2007ended Dec 31, 2007filed Aug 6, 2009
Revenue447,567400,278371,622324,162287,597257,141242,155226,247201,159184,840157,107130,474122,489110,618101,86294,15587,13881,18675,431
Cost of revenue50,65546,69438,77033,70331,03430,74528,11726,99824,11224,416—————————
Gross profit———————————————————
Research and development———————————————————
Selling, general and administrative59,59253,01354,62847,78242,57941,70435,19334,07429,55728,40124,31221,26318,94117,30615,55714,27012,73413,10310,583
Operating income18,96432,28732,35828,43523,97022,40519,68517,34415,20912,93011,02110,2749,6239,2548,4647,8646,3595,2637,849
Other income (expense)———————————————————
Pretax income14,69720,07129,11226,34322,31020,74217,98115,94414,02311,86310,2319,6568,9158,6227,9597,3835,8084,6247,305
Income tax1,8904,8295,9685,7044,5784,9733,7423,5623,2004,7904,3634,0373,2423,0962,8172,7491,9861,6472,651
Net income12,05614,40522,38120,12017,28515,40313,83911,98610,5587,0175,8135,6195,6255,5265,1424,6343,8222,9774,654
Diluted EPS ($)13.2315.5123.8621.1818.0816.0314.3312.1910.727.256.015.705.505.284.734.103.242.403.42
Diluted shares (millions)9119299389509569619669839859689679861,0231,0461,0871,1311,1791,2411,361

Balance sheet

UnitedHealth Group balance sheet, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Mar 2, 2026FY2024ended Dec 31, 2024filed Feb 27, 2025FY2023ended Dec 31, 2023filed Feb 28, 2024FY2022ended Dec 31, 2022filed Feb 24, 2023FY2021ended Dec 31, 2021filed Feb 15, 2022FY2020ended Dec 31, 2020filed Mar 1, 2021FY2019ended Dec 31, 2019filed Feb 14, 2020FY2018ended Dec 31, 2018filed Feb 12, 2019FY2017ended Dec 31, 2017filed Feb 13, 2018FY2016ended Dec 31, 2016filed Feb 8, 2017FY2015ended Dec 31, 2015filed Feb 9, 2016FY2014ended Dec 31, 2014filed Feb 10, 2015FY2013ended Dec 31, 2013filed Feb 12, 2014FY2012ended Dec 31, 2012filed Feb 7, 2013FY2011ended Dec 31, 2011filed Feb 9, 2012FY2010ended Dec 31, 2010filed Feb 10, 2011FY2009ended Dec 31, 2009filed Feb 10, 2010FY2008ended Dec 31, 2008filed Aug 6, 2009FY2007ended Dec 31, 2007filed Aug 6, 2009
Cash and equivalents24,36525,31225,42723,36521,37516,92110,98510,86611,98110,43010,9237,4957,2768,4069,4299,1239,8007,4268,865
Short-term investments3,7563,8014,2014,5462,5322,8603,2603,4583,5092,8451,9881,7411,9373,0312,5772,0721,239783—
Total current assets90,58285,77978,43769,06961,75853,71842,63438,69237,08433,87931,63923,55620,38021,05220,35018,39318,20014,990—
Total assets309,581298,278273,720245,705212,206197,289173,889152,221139,058122,810111,25486,30081,88280,88567,88963,06359,04555,815—
Total current liabilities114,897103,76999,05489,23778,29272,42061,78253,20950,46349,25242,89830,62327,88127,11623,92223,70022,16319,761—
Long-term debt72,32072,35958,26354,51342,38338,64836,80834,58128,83525,77725,33116,00714,89114,04110,6568,6629,00911,338—
Total liabilities207,883195,687174,801159,358135,727126,750111,72795,99487,03682,62175,79352,54048,55847,58639,59737,23835,43935,035—
Stockholders’ equity100,09098,26894,42181,45075,04568,32860,43654,31949,83338,17733,72532,45432,14931,178—————
Shares outstanding (millions)9089159229339419459499609689519519549891,0251,0451,0941,158——

Cash flow statement

UnitedHealth Group cash flow statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Mar 2, 2026FY2024ended Dec 31, 2024filed Feb 27, 2025FY2023ended Dec 31, 2023filed Feb 28, 2024FY2022ended Dec 31, 2022filed Feb 24, 2023FY2021ended Dec 31, 2021filed Feb 15, 2022FY2020ended Dec 31, 2020filed Mar 1, 2021FY2019ended Dec 31, 2019filed Feb 14, 2020FY2018ended Dec 31, 2018filed Feb 12, 2019FY2017ended Dec 31, 2017filed Feb 13, 2018FY2016ended Dec 31, 2016filed Feb 8, 2017FY2015ended Dec 31, 2015filed Feb 9, 2016FY2014ended Dec 31, 2014filed Feb 10, 2015FY2013ended Dec 31, 2013filed Feb 12, 2014FY2012ended Dec 31, 2012filed Feb 7, 2013FY2011ended Dec 31, 2011filed Feb 9, 2012FY2010ended Dec 31, 2010filed Feb 10, 2011FY2009ended Dec 31, 2009filed Feb 10, 2010FY2008ended Dec 31, 2008filed Aug 6, 2009FY2007ended Dec 31, 2007filed Aug 6, 2009
Operating cash flow19,69724,20429,06826,20622,34322,17418,46315,71313,5969,7959,7408,0516,9917,1556,9686,2735,6254,2385,877
Capital expenditures3,6223,4993,3862,8022,4542,0512,0712,0632,0231,7051,5561,5251,3071,0701,067878739791871
Free cash flow (CFO − capex)16,07520,70525,68223,40419,88920,12316,39213,65011,5738,0908,1846,5265,6846,0855,9015,3954,8863,4475,006
Depreciation and amortization4,3614,0993,9723,4003,1032,8912,7202,4282,2452,0551,6931,4781,3751,3091,1241,064991981796
Share repurchases5,5459,0008,0007,0005,0004,2505,5004,5001,5001,2801,2004,0083,1703,0842,9942,5171,8012,6846,599
Dividends paid7,9167,5336,7615,9915,2804,5843,9323,3202,7732,2611,7861,3621,056820651449363740

Insider activity

Form 4 filings by officers, directors and 10% owners, November 1, 2024 to November 1, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, three months
$661K
2 sales by 1 insider; officers and directors $661K
Bought, twelve months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, twelve months
$945K
3 sales by 1 insider; officers and directors $945K

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Oct 1, 2026Noseworthy John HDirectoraward240$0.00—7,902Oct 5, 2026
Oct 1, 2026Montgomery Rice Valerie MDDirectoraward257$0.00—8,180Oct 5, 2026
Oct 1, 2026Mcnabb Frederick William IIIDirectoraward291$0.00—15,810Oct 5, 2026
Oct 1, 2026Gottlieb ScottDirectoraward257$0.00—921Oct 5, 2026
Oct 1, 2026Gil KristenDirectoraward240$0.00—2,867Oct 5, 2026
Oct 1, 2026Garcia Paul RDirectoraward155$0.00—4,077Oct 5, 2026
Oct 1, 2026Garcia Paul RDirectoraward103$0.00—4,180Oct 5, 2026
Oct 1, 2026Flynn Timothy PatrickDirectoraward262$0.00—11,205Oct 5, 2026
Oct 1, 2026Baker Charles D.Directoraward257$0.00—2,668Oct 5, 2026
Sep 22, 2026Mcnabb Frederick William IIIDirectoraward57$0.00—15,519Sep 24, 2026
Sep 22, 2026Stankiewicz Dennis AndrewChief Accounting Officeraward51$0.00—10,109Sep 24, 2026
Sep 22, 2026Baker Charles D.Directoraward15$0.00—2,411Sep 24, 2026
Sep 22, 2026Flynn Timothy PatrickDirectoraward68$0.00—10,943Sep 24, 2026
Sep 22, 2026Noseworthy John HDirectoraward46$0.00—7,662Sep 24, 2026
Sep 22, 2026Gottlieb ScottDirectoraward5$0.00—664Sep 24, 2026
Sep 22, 2026Zaetta Christopher REVP & Chief Legal Officeraward67$0.00—15,927Sep 24, 2026
Sep 22, 2026Hemsley Stephen JCEO, UHG, Directoraward50$0.00—177,690Sep 24, 2026
Sep 22, 2026Montgomery Rice Valerie MDDirectoraward47$0.00—7,923Sep 24, 2026
Sep 22, 2026Garcia Paul RDirectoraward16$0.00—3,922Sep 24, 2026
Sep 22, 2026Gil KristenDirectoraward10$0.00—2,627Sep 24, 2026
Sep 22, 2026Conway Patrick HughChief Executive Officer, Optumaward91$0.00—15,419Sep 24, 2026
Sep 22, 2026DeVeydt Wayne SChief Financial Officeraward106$0.00—18,676Sep 24, 2026
Sep 22, 2026Noel Timothy JohnChief Executive Officer, UHCaward84$0.00—17,735Sep 24, 2026
Sep 22, 2026McSweeney ErinEVP & Chief People Officeraward53$0.00—15,654Sep 24, 2026
Sep 2, 2026DeVeydt Wayne SChief Financial Officertax withholding1,209$399.66$483K18,570Sep 4, 2026

Full insider history for UnitedHealth Group, or insider activity across all companies. A record of filings, not a recommendation.

Tracked funds holding it

1 of the tracked managers held UNH in their latest 13F filing, through August 14, 2026. Weight is the share of the fund’s reported portfolio. How the funds have traded UNH by quarter.

FundManagerQuarterValueSharesWeightMove
Baron Capital GroupRon BaronQ2 2026$4M10,0590.01%new

Sources

Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
UnitedHealth Group Incorporated, CIK 731766 on EDGAR
Extract generated
August 27, 2026
Withheld
1 line-years whose four quarters do not sum to the filed year: dividends FY2010
Repaired
none
XBRL concepts behind each line

Income statement

Revenue: Revenues
Cost of revenue: CostOfGoodsAndServicesSold
Gross profit: not filed
Research and development: not filed
Selling, general and administrative: SellingGeneralAndAdministrativeExpense
Operating income: OperatingIncomeLoss
Other income (expense): not filed
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest, IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: ShortTermInvestments
Total current assets: AssetsCurrent
Total assets: Assets
Total current liabilities: LiabilitiesCurrent
Long-term debt: LongTermDebtNoncurrent
Total liabilities: Liabilities
Stockholders’ equity: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquireProductiveAssets, PaymentsToAcquirePropertyPlantAndEquipment
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationAndAmortization
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: PaymentsOfDividends, PaymentsOfDividendsCommonStock

The data

The statements on this page as files, generated August 27, 2026.

JSON file
/data/financials/UNH.json